ong-term follow-up clinical study of cultured epithelial autografts (CEA, J-TEC-01) for patients with giant congenital melanocytic nevi.
Not Applicable
Completed
- Conditions
- Giant Congenital Melanocytic Nevus (GCMN)
- Registration Number
- JPRN-UMIN000013361
- Lead Sponsor
- Japan Tissue Engineering Co.,Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patients who are participating or will participate in other clinical studies. 2) The patients who are considered ineligible by the principal investigator or subinvestigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method State of the grafted site after complete epithelialization; incidence rates of adverse event and failure; safety
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the long-term outcomes of cultured epithelial autografts (J-TEC-01) in treating giant congenital melanocytic nevi?
How do cultured epithelial autografts (J-TEC-01) compare to standard-of-care treatments for GCMN in terms of efficacy and safety?
What biomarkers are associated with successful engraftment and response to J-TEC-01 in GCMN patients?
What adverse events have been reported with J-TEC-01 in long-term follow-up studies for GCMN?
Are there combination therapies or alternative approaches to J-TEC-01 for managing giant congenital melanocytic nevi?